509 related articles for article (PubMed ID: 15814793)
1. Apolipoprotein E genotype regulates amyloid-beta cytotoxicity.
Wilhelmus MM; Otte-Höller I; Davis J; Van Nostrand WE; de Waal RM; Verbeek MM
J Neurosci; 2005 Apr; 25(14):3621-7. PubMed ID: 15814793
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death.
Bruinsma IB; Wilhelmus MM; Kox M; Veerhuis R; de Waal RM; Verbeek MM
Brain Res; 2010 Feb; 1315():169-80. PubMed ID: 20034483
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-beta-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype.
Verbeek MM; Van Nostrand WE; Otte-Höller I; Wesseling P; De Waal RM
Ann N Y Acad Sci; 2000 Apr; 903():187-99. PubMed ID: 10818507
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
5. Neprilysin protects against cerebral amyloid angiopathy and Aβ-induced degeneration of cerebrovascular smooth muscle cells.
Miners JS; Kehoe P; Love S
Brain Pathol; 2011 Sep; 21(5):594-605. PubMed ID: 21382117
[TBL] [Abstract][Full Text] [Related]
6. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
Chen Q; Wang T; Kang D; Chen L
Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
[TBL] [Abstract][Full Text] [Related]
10. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
11. Increased CSF cortisol in AD is a function of APOE genotype.
Peskind ER; Wilkinson CW; Petrie EC; Schellenberg GD; Raskind MA
Neurology; 2001 Apr; 56(8):1094-8. PubMed ID: 11320185
[TBL] [Abstract][Full Text] [Related]
12. APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice.
Pankiewicz JE; Baquero-Buitrago J; Sanchez S; Lopez-Contreras J; Kim J; Sullivan PM; Holtzman DM; Sadowski MJ
Mol Neurodegener; 2017 Jan; 12(1):12. PubMed ID: 28143566
[TBL] [Abstract][Full Text] [Related]
13. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
14. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.
Riddell DR; Zhou H; Atchison K; Warwick HK; Atkinson PJ; Jefferson J; Xu L; Aschmies S; Kirksey Y; Hu Y; Wagner E; Parratt A; Xu J; Li Z; Zaleska MM; Jacobsen JS; Pangalos MN; Reinhart PH
J Neurosci; 2008 Nov; 28(45):11445-53. PubMed ID: 18987181
[TBL] [Abstract][Full Text] [Related]
15. Insulin inhibits amyloid beta-induced cell death in cultured human brain pericytes.
Rensink AA; Otte-Höller I; de Boer R; Bosch RR; ten Donkelaar HJ; de Waal RM; Verbeek MM; Kremer B
Neurobiol Aging; 2004 Jan; 25(1):93-103. PubMed ID: 14675735
[TBL] [Abstract][Full Text] [Related]
16. Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures.
Jordán J; Galindo MF; Miller RJ; Reardon CA; Getz GS; LaDu MJ
J Neurosci; 1998 Jan; 18(1):195-204. PubMed ID: 9412500
[TBL] [Abstract][Full Text] [Related]
17. Influence of LRP-1 and apolipoprotein E on amyloid-β uptake and toxicity to cerebrovascular smooth muscle cells.
Ruzali WA; Kehoe PG; Love S
J Alzheimers Dis; 2013; 33(1):95-110. PubMed ID: 22914594
[TBL] [Abstract][Full Text] [Related]
18. APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature.
Nelson PT; Pious NM; Jicha GA; Wilcock DM; Fardo DW; Estus S; Rebeck GW
J Neuropathol Exp Neurol; 2013 Jul; 72(7):708-15. PubMed ID: 23771217
[TBL] [Abstract][Full Text] [Related]
19. Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.
Salvadó G; Grothe MJ; Groot C; Moscoso A; Schöll M; Gispert JD; Ossenkoppele R;
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2212-2224. PubMed ID: 33521872
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan.
Fu Y; Zhao J; Atagi Y; Nielsen HM; Liu CC; Zheng H; Shinohara M; Kanekiyo T; Bu G
Mol Neurodegener; 2016 May; 11(1):37. PubMed ID: 27151330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
